Keyword: Johnson & Johnson

News

Latest J&J Recall Involves Sterility Problems

03.03.2011 - Johnson & Johnson, which has been plagued by repeated recalls of its consumer medicines and medical devices over the past year, on Wednesday said it recalled 107 batches of...

Plant Construction & Process Technology

Patent Cliff To Intensify in the U.S. in 2011

21.01.2011 - Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic...

News

Johnson & Johnson Blames Cleaning Procedures in Massive Recalls

17.01.2011 - Johnson & Johnson faulted lax cleaning procedures and other problems at a manufacturing plant behind massive recalls of medicines like Tylenol, and said it was recalling nearly 50...

News

Smith & Nephew Rejects $11 Billion Bid from Johnson & Johnson

10.01.2011 - British medical equipment company Smith & Nephew rejected a 7 billion pound ($10.9 billion) takeover approach from U.S. rival Johnson & Johnson late last year, Sky News said...

News

Fort Washington: U.S. FDA Discovers More Problems at J&J Plant

16.12.2010 - U.S. inspectors are still uncovering a host of problems at a Johnson & Johnson manufacturing plant that was the source of a major recall of dozens of popular children's medications...

News

Alex Gorsky and Sheri McCoy Named Vice Chairs of Johnson & Johnson Executive Committee

16.12.2010 - Johnson & Johnson promoted the heads of its medical device unit and its pharmaceuticals division to vice chairmen on Wednesday, a move that could put them in competition to succeed...

News

Softchews' Recall Grows As Wood, Metal Found

13.12.2010 - Johnson & Johnson issued a recall of its Softchews Rolaids antacids on Thursday after consumers reported finding wood and metal bits in the tablets. J&J, which recalled some...

News

Crucell Bid: J&J Eyes Vaccine Market

08.12.2010 - U.S. healthcare group Johnson & Johnson made a long-awaited €1.75 billion bid for Crucell on Wednesday, shrugging off the Dutch biotech company's recent problems with vaccine...